Insider Trading disclosures for G1 Therapeutics Inc

The latest disclosure was made by Glenn P. Muir in G1 Therapeutics Inc where a trade of 30,000 Stock Option (right to buy) done was reported to US exchanges on Sept. 18, 2024.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Glenn P. Muir	Director	Sale or transfer of securities back to the company at price $ 0.00 per share.	18 Sep 2024	30,000	0	-		-	Stock Option (right to buy)
Glenn P. Muir	Director	Sale or transfer of securities back to the company at price $ 0.00 per share.	18 Sep 2024	30,000	0	-		-	Stock Option (right to buy)
Glenn P. Muir	Director	Sale or transfer of securities back to the company at price $ 0.00 per share.	18 Sep 2024	30,000	0	-		-	Stock Option (right to buy)
Glenn P. Muir	Director	Sale or transfer of securities back to the company at price $ 0.00 per share.	18 Sep 2024	50,000	0	-		-	Stock Option (right to buy)
Glenn P. Muir	Director	Sale or transfer of securities back to the company at price $ 0.00 per share.	18 Sep 2024	20,000	185,358 (0%)	0%		-	Common Stock
Glenn P. Muir	Director		18 Sep 2024	185,358	0 (0%)	0%		-	Common Stock
Terry L. Murdock	Chief Operating Officer	Sale or transfer of securities back to the company at price $ 0.00 per share.	18 Sep 2024	74,500	0	-		-	Stock Option (right to buy)
Terry L. Murdock	Chief Operating Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	18 Sep 2024	17,900	145,912 (0%)	0%		-	Common Stock
Terry L. Murdock	Chief Operating Officer	Sale or transfer of securities back to the company at price $ 0.00 per share.	18 Sep 2024	124,762	21,150 (0%)	0%		-	Common Stock
Terry L. Murdock	Chief Operating Officer		18 Sep 2024	21,150	0 (0%)	0%		-	Common Stock
Terry L. Murdock	Chief Operating Officer	Sale or transfer of securities back to the company at price $ 0.00 per share.	18 Sep 2024	35,700	0	-		-	Stock Option (right to buy)
Rajesh K. Malik	Chief Medical Officer	Sale or transfer of securities back to the company at price $ 0.00 per share.	18 Sep 2024	57,333	0	-		-	Stock Option (right to buy)
Rajesh K. Malik	Chief Medical Officer	Sale or transfer of securities back to the company at price $ 0.00 per share.	18 Sep 2024	35,700	0	-		-	Stock Option (right to buy)
Rajesh K. Malik	Chief Medical Officer	Sale or transfer of securities back to the company at price $ 0.00 per share.	18 Sep 2024	36,924	0	-		-	Stock Option (right to buy)
Rajesh K. Malik	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	18 Sep 2024	17,900	177,212 (0%)	0%		-	Common Stock
Rajesh K. Malik	Chief Medical Officer	Sale or transfer of securities back to the company at price $ 0.00 per share.	18 Sep 2024	89,762	87,450 (0%)	0%		-	Common Stock
Rajesh K. Malik	Chief Medical Officer		18 Sep 2024	87,450	0 (0%)	0%		-	Common Stock
Rajesh K. Malik	Chief Medical Officer	Sale or transfer of securities back to the company at price $ 0.00 per share.	18 Sep 2024	74,500	0	-		-	Stock Option (right to buy)
Alicia Secor	Director	Sale or transfer of securities back to the company at price $ 0.00 per share.	18 Sep 2024	30,000	0	-		-	Stock Option (right to buy)
Alicia Secor	Director	Sale or transfer of securities back to the company at price $ 0.00 per share.	18 Sep 2024	20,000	10,000 (0%)	0%		-	Common Stock
Alicia Secor	Director		18 Sep 2024	10,000	0 (0%)	0%		-	Common Stock
Alicia Secor	Director	Sale or transfer of securities back to the company at price $ 0.00 per share.	18 Sep 2024	30,000	0	-		-	Stock Option (right to buy)
Alicia Secor	Director	Sale or transfer of securities back to the company at price $ 0.00 per share.	18 Sep 2024	30,000	0	-		-	Stock Option (right to buy)
Garry A. Nicholson	Director		18 Sep 2024	14,389	0 (0%)	0%		-	Common Stock
Garry A. Nicholson	Director	Sale or transfer of securities back to the company at price $ 0.00 per share.	18 Sep 2024	30,000	0	-		-	Stock Option (right to buy)
Garry A. Nicholson	Director	Sale or transfer of securities back to the company at price $ 0.00 per share.	18 Sep 2024	30,000	0	-		-	Stock Option (right to buy)
Garry A. Nicholson	Director	Sale or transfer of securities back to the company at price $ 0.00 per share.	18 Sep 2024	30,000	0	-		-	Stock Option (right to buy)
Garry A. Nicholson	Director	Sale or transfer of securities back to the company at price $ 0.00 per share.	18 Sep 2024	20,000	14,389 (0%)	0%		-	Common Stock
Cynthia L. Flowers	Director	Sale or transfer of securities back to the company at price $ 0.00 per share.	18 Sep 2024	30,000	0	-		-	Stock Option (right to buy)
Cynthia L. Flowers	Director		18 Sep 2024	15,889	0 (0%)	0%		-	Common Stock
Cynthia L. Flowers	Director	Sale or transfer of securities back to the company at price $ 0.00 per share.	18 Sep 2024	20,000	15,889 (0%)	0%		-	Common Stock
Cynthia L. Flowers	Director	Sale or transfer of securities back to the company at price $ 0.00 per share.	18 Sep 2024	30,000	0	-		-	Stock Option (right to buy)
Cynthia L. Flowers	Director	Sale or transfer of securities back to the company at price $ 0.00 per share.	18 Sep 2024	30,000	0	-		-	Stock Option (right to buy)
Mark Avagliano	Chief Business Officer	Sale or transfer of securities back to the company at price $ 0.00 per share.	18 Sep 2024	89,400	0	-		-	Stock Option (right to buy)
Mark Avagliano	Chief Business Officer	Sale or transfer of securities back to the company at price $ 0.00 per share.	18 Sep 2024	236,610	26,035 (0%)	0%		-	Common Stock
Mark Avagliano	Chief Business Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	18 Sep 2024	20,600	262,645 (0%)	0%		-	Common Stock
Mark Avagliano	Chief Business Officer	Sale or transfer of securities back to the company at price $ 0.00 per share.	18 Sep 2024	41,100	0	-		-	Stock Option (right to buy)
Mark Avagliano	Chief Business Officer		18 Sep 2024	26,035	0 (0%)	0%		-	Common Stock
John E. Bailey	Director, President and CEO	Sale or transfer of securities back to the company at price $ 0.00 per share.	18 Sep 2024	201,300	0	-		-	Stock Option (right to buy)
John E. Bailey	Director, President and CEO	Sale or transfer of securities back to the company at price $ 0.00 per share.	18 Sep 2024	534,787	196,287 (0%)	1%		-	Common Stock
John E. Bailey	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	18 Sep 2024	181,400	731,074 (1%)	0%		-	Common Stock
John E. Bailey	Director, President and CEO	Sale or transfer of securities back to the company at price $ 0.00 per share.	18 Sep 2024	161,300	0	-		-	Stock Option (right to buy)
John E. Bailey	Director, President and CEO		18 Sep 2024	196,287	0 (0%)	0%		-	Common Stock
Andrew Perry	Chief Commercial Officer	Sale or transfer of securities back to the company at price $ 0.00 per share.	18 Sep 2024	114,482	14,232 (0%)	0%		-	Common Stock
Andrew Perry	Chief Commercial Officer		18 Sep 2024	14,232	0 (0%)	0%		-	Common Stock
Andrew Perry	Chief Commercial Officer	Sale or transfer of securities back to the company at price $ 0.00 per share.	18 Sep 2024	67,050	0	-		-	Stock Option (right to buy)
Andrew Perry	Chief Commercial Officer	Sale or transfer of securities back to the company at price $ 0.00 per share.	18 Sep 2024	32,100	0	-		-	Stock Option (right to buy)
Andrew Perry	Chief Commercial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	18 Sep 2024	16,100	128,714 (0%)	0%		-	Common Stock
Jacks Lee	Director	Sale or transfer of securities back to the company at price $ 0.00 per share.	18 Sep 2024	10,000	10,000 (0%)	0%		-	Common Stock
Jacks Lee	Director	Sale or transfer of securities back to the company at price $ 0.00 per share.	18 Sep 2024	60,000	0	-		-	Stock Option (right to buy)
Jacks Lee	Director	Sale or transfer of securities back to the company at price $ 0.00 per share.	18 Sep 2024	30,000	0	-		-	Stock Option (right to buy)
Jacks Lee	Director	Sale or transfer of securities back to the company at price $ 0.00 per share.	18 Sep 2024	30,000	0	-		-	Stock Option (right to buy)
Jacks Lee	Director		18 Sep 2024	10,000	0 (0%)	0%		-	Common Stock
Norman E. Sharpless	Director	Sale or transfer of securities back to the company at price $ 0.00 per share.	18 Sep 2024	30,000	0	-		-	Stock Option (right to buy)
Norman E. Sharpless	Director	Sale or transfer of securities back to the company at price $ 0.00 per share.	18 Sep 2024	30,000	0	-		-	Stock Option (right to buy)
Norman E. Sharpless	Director	Sale or transfer of securities back to the company at price $ 0.00 per share.	18 Sep 2024	20,000	0 (0%)	0%		-	Common Stock
John W. Umstead	Chief Financial Officer	Sale or transfer of securities back to the company at price $ 0.00 per share.	18 Sep 2024	100,000	0	-		-	Stock Option (right to buy)
John W. Umstead	Chief Financial Officer		18 Sep 2024	19,331	0 (0%)	0%		-	Common Stock
John W. Umstead	Chief Financial Officer	Sale or transfer of securities back to the company at price $ 0.00 per share.	18 Sep 2024	74,500	0	-		-	Stock Option (right to buy)
John W. Umstead	Chief Financial Officer	Sale or transfer of securities back to the company at price $ 0.00 per share.	18 Sep 2024	6,000	0	-		-	Stock Option (right to buy)
John W. Umstead	Chief Financial Officer	Sale or transfer of securities back to the company at price $ 0.00 per share.	18 Sep 2024	168,387	19,331 (0%)	0%		-	Common Stock
Monica R. Thomas	Chief Legal & People Officer		18 Sep 2024	6,674	0 (0%)	0%		-	Common Stock
Monica R. Thomas	Chief Legal & People Officer	Sale or transfer of securities back to the company at price $ 0.00 per share.	18 Sep 2024	150,000	0	-		-	Stock Option (right to buy)
Monica R. Thomas	Chief Legal & People Officer	Sale or transfer of securities back to the company at price $ 0.00 per share.	18 Sep 2024	55,875	0	-		-	Stock Option (right to buy)
Monica R. Thomas	Chief Legal & People Officer	Sale or transfer of securities back to the company at price $ 0.00 per share.	18 Sep 2024	138,151	6,674 (0%)	0%		-	Common Stock
Terry L. Murdock	Chief Operating Officer	Sale of securities on an exchange or to another person at price $ 2.51 per share.	05 Jul 2024	2,475	128,012 (0%)	0%	2.5	6,207	Common Stock
Rajesh K. Malik	Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 2.51 per share.	05 Jul 2024	2,475	159,312 (0%)	0%	2.5	6,207	Common Stock
Mark Avagliano	Chief Business Officer	Sale of securities on an exchange or to another person at price $ 2.51 per share.	05 Jul 2024	2,638	242,045 (0%)	0%	2.5	6,615	Common Stock
John E. Bailey	Director, President and CEO	Sale of securities on an exchange or to another person at price $ 2.51 per share.	05 Jul 2024	7,662	549,674 (1%)	0%	2.5	19,214	Common Stock
Andrew Perry	Chief Commercial Officer	Sale of securities on an exchange or to another person at price $ 2.51 per share.	05 Jul 2024	1,337	112,614 (0%)	0%	2.5	3,353	Common Stock
John W. Umstead	Chief Financial Officer	Sale of securities on an exchange or to another person at price $ 2.51 per share.	05 Jul 2024	527	187,718 (0%)	0%	2.5	1,322	Common Stock
Terry L. Murdock	Chief Operating Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Jul 2024	35,000	130,487 (0%)	0%		0	Common Stock
Mark Avagliano	Chief Business Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Jul 2024	35,000	244,683 (0%)	0%		0	Common Stock
John E. Bailey	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Jul 2024	105,000	557,336 (1%)	0%		0	Common Stock
Andrew Perry	Chief Commercial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Jul 2024	35,000	113,951 (0%)	0%		0	Common Stock
John W. Umstead	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Jul 2024	35,000	188,245 (0%)	0%		0	Common Stock
Monica R. Thomas	Chief Legal & People Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Jul 2024	35,000	144,825 (0%)	0%		0	Common Stock
Glenn P. Muir	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Jun 2024	10,000	205,358 (0%)	0%		0	Common Stock
Glenn P. Muir	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Jun 2024	30,000	30,000	-		-	Stock Options (Right to Buy)
Alicia Secor	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Jun 2024	10,000	30,000 (0%)	0%		0	Common Stock
Alicia Secor	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Jun 2024	30,000	30,000	-		-	Stock Options (Right to Buy)
Garry A. Nicholson	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Jun 2024	30,000	30,000	-		-	Stock Options (Right to Buy)
Garry A. Nicholson	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Jun 2024	10,000	34,389 (0%)	0%		0	Common Stock
Cynthia L. Flowers	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Jun 2024	30,000	30,000	-		-	Stock Options (Right to Buy)
Cynthia L. Flowers	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Jun 2024	10,000	35,889 (0%)	0%		0	Common Stock
Jacks Lee	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Jun 2024	10,000	20,000 (0%)	0%		0	Common Stock
Jacks Lee	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Jun 2024	30,000	30,000	-		-	Stock Options (Right to Buy)
Norman E. Sharpless	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Jun 2024	10,000	20,000 (0%)	0%		0	Common Stock
Norman E. Sharpless	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Jun 2024	30,000	30,000	-		-	Stock Options (Right to Buy)
Monica R. Thomas	Chief Legal & People Officer	Sale of securities on an exchange or to another person at price $ 4.27 per share.	23 May 2024	5,826	109,825 (0%)	0%	4.3	24,864	Common Stock
Terry L. Murdock	Chief Operating Officer	Sale of securities on an exchange or to another person at price $ 4.79 per share.	13 May 2024	8,151	95,487 (0%)	0%	4.8	39,034	Common Stock
Rajesh K. Malik	Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 4.79 per share.	13 May 2024	8,151	161,787 (0%)	0%	4.8	39,034	Common Stock
Mark Avagliano	Chief Business Officer	Sale of securities on an exchange or to another person at price $ 4.79 per share.	13 May 2024	8,151	209,683 (0%)	0%	4.8	39,034	Common Stock
John E. Bailey	Director, President and CEO	Sale of securities on an exchange or to another person at price $ 4.79 per share.	13 May 2024	37,258	452,336 (1%)	0%	4.8	178,421	Common Stock
Andrew Perry	Chief Commercial Officer	Sale of securities on an exchange or to another person at price $ 4.79 per share.	13 May 2024	8,151	78,951 (0%)	0%	4.8	39,034	Common Stock
John W. Umstead	Chief Financial Officer	Sale of securities on an exchange or to another person at price $ 4.79 per share.	13 May 2024	8,151	153,245 (0%)	0%	4.8	39,034	Common Stock
Mark Avagliano	Chief Business Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Mar 2024	100,000	217,834 (0%)	0%		0	Common Stock
John W. Umstead	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Mar 2024	37,500	161,396 (0%)	0%		0	Common Stock
Monica R. Thomas	General Counsel	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Mar 2024	37,500	115,651 (0%)	0%		0	Common Stock
John W. Umstead	Chief Financial Officer	Sale of securities on an exchange or to another person at price $ 3.02 per share.	18 Mar 2024	6,547	123,896 (0%)	0%	3.0	19,752	Common Stock
Malik Rajesh K.	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	12 Feb 2024	28,600	0	-		-	Stock Option (Right to Buy)
Rajesh K. Malik	Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 4.62 per share.	12 Feb 2024	28,600	169,938 (0%)	0%	4.6	132,143	Common Stock
Rajesh Malik K.	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.30 per share.	12 Feb 2024	28,600	198,538 (0%)	0%	0.3	8,580	Common Stock
Thomas R. Monica	General Counsel	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2024	55,875	55,875	-		-	Stock Options (Right to Buy)
Avagliano Mark	Chief Business Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2024	44,760	121,915 (0%)	0%		0	Common Stock
Murdock L. Terry	Chief Operating Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2024	74,500	74,500	-		-	Stock Options (Right to Buy)
L. Terry Murdock	Chief Operating Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2024	37,300	107,378 (0%)	0%		0	Common Stock
K. Malik Rajesh	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2024	74,500	74,500	-		-	Stock Options (Right to Buy)
Malik Rajesh K.	Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 2.94 per share.	03 Jan 2024	721	169,938 (0%)	0%	2.9	2,121	Common Stock
W. John Umstead	Chief Financial Officer	Sale of securities on an exchange or to another person at price $ 3.12 per share.	03 Jan 2024	253	130,933 (0%)	0%	3.1	789	Common Stock
K. Rajesh Malik	Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 3.12 per share.	03 Jan 2024	758	172,920 (0%)	0%	3.1	2,364	Common Stock
Malik K. Rajesh	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2024	37,300	173,678 (0%)	0%		0	Common Stock
Avagliano Mark	Chief Business Officer	Sale of securities on an exchange or to another person at price $ 3.12 per share.	03 Jan 2024	2,602	118,555 (0%)	0%	3.1	8,115	Common Stock
Avagliano Mark	Chief Business Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2024	89,400	89,400	-		-	Stock Options (Right to Buy)
W. John Umstead	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2024	37,300	131,186 (0%)	0%		0	Common Stock
L. Terry Murdock	Chief Operating Officer	Sale of securities on an exchange or to another person at price $ 3.12 per share.	03 Jan 2024	758	106,620 (0%)	0%	3.1	2,364	Common Stock
Malik K. Rajesh	Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 3.12 per share.	03 Jan 2024	2,261	170,659 (0%)	0%	3.1	7,052	Common Stock
Perry Andrew	Chief Commercial Officer	Sale of securities on an exchange or to another person at price $ 3.12 per share.	03 Jan 2024	379	89,136 (0%)	0%	3.1	1,182	Common Stock
Bailey E. John	Director, President and CEO	Sale of securities on an exchange or to another person at price $ 3.12 per share.	03 Jan 2024	2,592	498,688 (1%)	0%	3.1	8,084	Common Stock
Umstead John W.	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2024	74,500	74,500	-		-	Stock Options (Right to Buy)
Bailey John E.	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2024	201,300	201,300	-		-	Stock Options (Right to Buy)
Andrew Perry	Chief Commercial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2024	33,570	89,515 (0%)	0%		0	Common Stock
Murdock L. Terry	Chief Operating Officer	Sale of securities on an exchange or to another person at price $ 2.94 per share.	03 Jan 2024	721	103,638 (0%)	0%	2.9	2,121	Common Stock
R. Thomas Monica	General Counsel	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2024	27,975	78,151 (0%)	0%		0	Common Stock
Umstead John W.	Chief Financial Officer	Sale of securities on an exchange or to another person at price $ 2.95 per share.	03 Jan 2024	111	130,443 (0%)	0%	2.9	327	Common Stock
Terry Murdock L.	Chief Operating Officer	Sale of securities on an exchange or to another person at price $ 3.12 per share.	03 Jan 2024	2,261	104,359 (0%)	0%	3.1	7,052	Common Stock
Perry Andrew	Chief Commercial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2024	67,050	67,050	-		-	Stock Options (Right to Buy)
John Umstead W.	Chief Financial Officer	Sale of securities on an exchange or to another person at price $ 3.12 per share.	03 Jan 2024	379	130,554 (0%)	0%	3.1	1,182	Common Stock
Avagliano Mark	Chief Business Officer	Sale of securities on an exchange or to another person at price $ 2.94 per share.	03 Jan 2024	721	117,834 (0%)	0%	2.9	2,121	Common Stock
Mark Avagliano	Chief Business Officer	Sale of securities on an exchange or to another person at price $ 3.12 per share.	03 Jan 2024	758	121,157 (0%)	0%	3.1	2,364	Common Stock
John Bailey E.	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2024	100,700	501,280 (1%)	0%		0	Common Stock
Bailey John E.	Director, President and CEO	Sale of securities on an exchange or to another person at price $ 3.12 per share.	03 Jan 2024	9,094	489,594 (1%)	0%	3.1	28,363	Common Stock
Andrew Perry	Chief Commercial Officer	Sale of securities on an exchange or to another person at price $ 3.12 per share.	03 Jan 2024	2,034	87,102 (0%)	0%	3.1	6,344	Common Stock
Bailey E. John	Director, President and CEO	Sale of securities on an exchange or to another person at price $ 3.27 per share.	02 Jan 2024	32,983	400,580 (1%)	0%	3.3	108,006	Common Stock
K. Malik Rajesh	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.30 per share.	11 Dec 2023	12,400	148,778 (0%)	0%	0.3	3,720	Common Stock
Malik Rajesh K.	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.39 per share.	11 Dec 2023	21,439	157,817 (0%)	0%	0.4	8,361	Common Stock
Rajesh Malik K.	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	11 Dec 2023	12,400	28,600	-		-	Stock Option (Right to Buy)
K. Malik Rajesh	Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 4.02 per share.	11 Dec 2023	12,400	136,378 (0%)	0%	4.0	49,863	Common Stock
Rajesh Malik K.	Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 3.06 per share.	11 Dec 2023	21,439	136,378 (0%)	0%	3.1	65,659	Common Stock
Malik K. Rajesh	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	11 Dec 2023	21,439	0	-		-	Stock Options (Right to Buy)
Mark A. Velleca	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	08 Aug 2023	2,714	242,286	-		-	Stock Option (Right to Buy)
Mark A. Velleca	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.39 per share.	08 Aug 2023	57,286	173,286 (0%)	0%	0.4	22,342	Common Stock
Mark A. Velleca	Director	Sale of securities on an exchange or to another person at price $ 2.00 per share.	08 Aug 2023	57,286	116,000 (0%)	0%	2.0	114,492	Common Stock
Mark A. Velleca	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.30 per share.	08 Aug 2023	2,714	118,714 (0%)	0%	0.3	814	Common Stock
Mark A. Velleca	Director	Sale of securities on an exchange or to another person at price $ 2.02 per share.	08 Aug 2023	2,714	116,000 (0%)	0%	2.0	5,482	Common Stock
Mark A. Velleca	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	08 Aug 2023	57,286	0	-		-	Stock Option (Right to Buy)
Terry L. Murdock	Chief Operating Officer	Sale of securities on an exchange or to another person at price $ 2.45 per share.	05 Jul 2023	1,361	70,078 (0%)	0%	2.5	3,339	Common Stock
Rajesh K. Malik	Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 2.45 per share.	05 Jul 2023	1,361	136,378 (0%)	0%	2.5	3,339	Common Stock
John E. Bailey	Director, President and CEO	Sale of securities on an exchange or to another person at price $ 2.45 per share.	05 Jul 2023	2,719	433,563 (1%)	0%	2.5	6,672	Common Stock
Andrew Perry	Chief Commercial Officer	Sale of securities on an exchange or to another person at price $ 2.45 per share.	05 Jul 2023	355	55,945 (0%)	0%	2.5	871	Common Stock
Glenn P. Muir	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Jun 2023	30,000	30,000	-		-	Stock Options (Right to Buy)
Glenn P. Muir	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Jun 2023	10,000	195,358 (0%)	0%		0	Common Stock
Alicia Secor	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Jun 2023	30,000	30,000	-		-	Stock Options (Right to Buy)
Alicia Secor	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Jun 2023	10,000	20,000 (0%)	0%		0	Common Stock
Garry A. Nicholson	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Jun 2023	30,000	30,000	-		-	Stock Options (Right to Buy)
Garry A. Nicholson	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Jun 2023	10,000	24,389 (0%)	0%		0	Common Stock
Cynthia L. Flowers	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Jun 2023	30,000	30,000	-		-	Stock Options (Right to Buy)
Cynthia L. Flowers	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Jun 2023	10,000	25,889 (0%)	0%		0	Common Stock
Jacks Lee	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Jun 2023	10,000	10,000 (0%)	0%		0	Common Stock
Jacks Lee	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Jun 2023	30,000	30,000	-		-	Stock Options (Right to Buy)
Norman E. Sharpless	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Jun 2023	10,000	10,000 (0%)	0%		0	Common Stock
Norman E. Sharpless	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Jun 2023	30,000	30,000	-		-	Stock Options (Right to Buy)
Monica R. Thomas	General Counsel	Grant, award, or other acquisition of securities at price $ 0.00 per share.	22 May 2023	150,000	150,000	-		-	Stock Options (Right to buy)
Monica R. Thomas	General Counsel	Grant, award, or other acquisition of securities at price $ 0.00 per share.	22 May 2023	50,000	50,176 (0%)	0%		0	Common Stock
Terry L. Murdock	Chief Operating Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 May 2023	35,000	71,439 (0%)	0%		0	Common Stock
Rajesh K. Malik	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 May 2023	35,000	137,739 (0%)	0%		0	Common Stock
Mark Avagliano	Chief Business Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 May 2023	35,000	77,155 (0%)	0%		0	Common Stock
John E. Bailey	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 May 2023	160,000	436,282 (1%)	0%		0	Common Stock
Andrew Perry	Chief Commercial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 May 2023	35,000	56,300 (0%)	0%		0	Common Stock
John W. Umstead	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 May 2023	35,000	93,886 (0%)	0%		0	Common Stock
John W. Umstead	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Mar 2023	50,000	58,886 (0%)	0%		0	Common Stock
John W. Umstead	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Mar 2023	100,000	100,000	-		-	Stock Options (Right to Buy)
Terry L. Murdock	Chief Operating Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2023	35,700	35,700	-		-	Stock Options (Right to buy)
Terry L. Murdock	Chief Operating Officer	Sale of securities on an exchange or to another person at price $ 5.41 per share.	03 Jan 2023	729	36,439 (0%)	0%	5.4	3,942	Common Stock
Terry L. Murdock	Chief Operating Officer	Sale of securities on an exchange or to another person at price $ 5.58 per share.	03 Jan 2023	1,639	37,168 (0%)	0%	5.6	9,138	Common Stock
Terry L. Murdock	Chief Operating Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2023	17,900	38,807 (0%)	0%		0	Common Stock
Rajesh K. Malik	Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 5.58 per share.	03 Jan 2023	1,639	103,468 (0%)	0%	5.6	9,138	Common Stock
Rajesh K. Malik	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2023	35,700	35,700	-		-	Stock Options (Right to buy)
Rajesh K. Malik	Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 5.41 per share.	03 Jan 2023	729	102,739 (0%)	0%	5.4	3,942	Common Stock
Rajesh K. Malik	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2023	17,900	105,107 (0%)	0%		0	Common Stock
Jennifer K. Moses	CFO	Sale of securities on an exchange or to another person at price $ 5.41 per share.	03 Jan 2023	729	57,820 (0%)	0%	5.4	3,942	Common Stock
Jennifer K. Moses	CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2023	44,600	44,600	-		-	Stock Options (Right to buy)
Jennifer K. Moses	CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2023	22,300	60,188 (0%)	0%		0	Common Stock
Jennifer K. Moses	CFO	Sale of securities on an exchange or to another person at price $ 5.58 per share.	03 Jan 2023	1,639	58,549 (0%)	0%	5.6	9,138	Common Stock
James S. Hanson	General Counsel	Sale of securities on an exchange or to another person at price $ 5.41 per share.	03 Jan 2023	729	41,087 (0%)	0%	5.4	3,942	Common Stock
James S. Hanson	General Counsel	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2023	17,900	43,455 (0%)	0%		0	Common Stock
James S. Hanson	General Counsel	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2023	35,700	35,700	-		-	Stock Options (Right to buy)
James S. Hanson	General Counsel	Sale of securities on an exchange or to another person at price $ 5.58 per share.	03 Jan 2023	1,639	41,816 (0%)	0%	5.6	9,138	Common Stock
Mark Avagliano	Chief Business Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2023	20,600	42,155 (0%)	0%		0	Common Stock
Mark Avagliano	Chief Business Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2023	41,100	41,100	-		-	Stock Options (Right to buy)
John E. Bailey	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2023	80,700	313,908 (0%)	0%		0	Common Stock
John E. Bailey	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2023	161,300	161,300	-		-	Stock Options (Right to buy)
John E. Bailey	Director, President and CEO	Sale of securities on an exchange or to another person at price $ 5.58 per share.	03 Jan 2023	5,607	276,282 (0%)	0%	5.6	31,262	Common Stock
John E. Bailey	Director, President and CEO	Sale of securities on an exchange or to another person at price $ 5.85 per share.	03 Jan 2023	32,019	281,889 (0%)	0%	5.9	187,452	Common Stock
Andrew Perry	Chief Commercial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2023	16,100	22,120 (0%)	0%		0	Common Stock
Andrew Perry	Chief Commercial Officer	Sale of securities on an exchange or to another person at price $ 5.58 per share.	03 Jan 2023	820	21,300 (0%)	0%	5.6	4,572	Common Stock
Andrew Perry	Chief Commercial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2023	32,100	32,100	-		-	Stock Options (Right to buy)
Mark A. Velleca	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	18 Oct 2022	15,000	57,286	-		-	Stock Option (Right to Buy)
Mark A. Velleca	Director	Sale of securities on an exchange or to another person at price $ 11.70 per share.	18 Oct 2022	15,000	116,000 (0%)	0%	11.7	175,490	Common Stock
Mark A. Velleca	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.39 per share.	18 Oct 2022	15,000	131,000 (0%)	0%	0.4	5,850	Common Stock
Mark A. Velleca	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.39 per share.	20 Sep 2022	20,000	136,000 (0%)	0%	0.4	7,800	Common Stock
Mark A. Velleca	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	20 Sep 2022	20,000	72,286	-		-	Stock Option (Right to Buy)
Mark A. Velleca	Director	Sale of securities on an exchange or to another person at price $ 13.50 per share.	20 Sep 2022	20,000	116,000 (0%)	0%	13.5	270,044	Common Stock
Rajesh K. Malik	Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 15.71 per share.	13 Sep 2022	18,000	73,207 (0%)	0%	15.7	282,746	Common Stock
Rajesh K. Malik	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	13 Sep 2022	18,000	21,439	-		-	Stock Options (Right to Buy)
Rajesh K. Malik	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.39 per share.	13 Sep 2022	18,000	91,207 (0%)	0%	0.4	7,020	Common Stock
Mark A. Velleca	Director	Sale of securities on an exchange or to another person at price $ 12.64 per share.	16 Aug 2022	80,000	116,000 (0%)	0%	12.6	1,010,904	Common Stock
Mark A. Velleca	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	16 Aug 2022	80,000	92,286	-		-	Stock Option (Right to Buy)
Mark A. Velleca	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.39 per share.	16 Aug 2022	80,000	196,000 (0%)	0%	0.4	31,200	Common Stock
Norman E. Sharpless	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	04 Aug 2022	60,000	60,000	-		-	Stock Options (Right to Buy)
Terry L. Murdock	Chief Operating Officer	Sale of securities on an exchange or to another person at price $ 5.17 per share.	05 Jul 2022	648	20,907 (0%)	0%	5.2	3,351	Common Stock
Rajesh K. Malik	Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 5.17 per share.	05 Jul 2022	648	73,207 (0%)	0%	5.2	3,351	Common Stock
Jacks Lee	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Jun 2022	60,000	60,000	-		-	Stock Options (Right to buy)
Glenn P. Muir	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2022	10,000	185,358 (0%)	0%		0	Common Stock
Glenn P. Muir	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2022	30,000	30,000	-		-	Stock Options (Right to Buy)
Willie A. Deese	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2022	10,000	14,389 (0%)	0%		0	Common Stock
Willie A. Deese	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2022	30,000	30,000	-		-	Stock Options (Right to Buy)
Alicia Secor	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2022	30,000	30,000	-		-	Stock Options (Right to Buy)
Alicia Secor	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2022	10,000	10,000 (0%)	0%		0	Common Stock
Garry A. Nicholson	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2022	30,000	30,000	-		-	Stock Options (Right to Buy)
Garry A. Nicholson	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2022	10,000	14,389 (0%)	0%		0	Common Stock
Cynthia L. Flowers	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2022	10,000	15,889 (0%)	0%		0	Common Stock
Cynthia L. Flowers	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2022	30,000	30,000	-		-	Stock Options (Right to Buy)
Mark A. Velleca	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	07 Feb 2022	15,000	172,286	-		-	Stock Options (Right to Buy)
Mark A. Velleca	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.39 per share.	07 Feb 2022	15,000	116,000 (0%)	0%	0.4	5,850	Common Stock
Rajesh K. Malik	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.30 per share.	01 Feb 2022	10,000	73,855 (0%)	0%	0.3	3,000	Common Stock
Rajesh K. Malik	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Feb 2022	10,000	55,000	-		-	Stock Option (Right to Buy)
Jennifer K. Moses	CFO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Feb 2022	333	0	-		-	Stock Options (Right to Buy)
Jennifer K. Moses	CFO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Feb 2022	2,000	58,000	-		-	Stock Option (Right to Buy)
Jennifer K. Moses	CFO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.17 per share.	01 Feb 2022	2,000	37,888 (0%)	0%	4.2	8,340	Common Stock
Jennifer K. Moses	CFO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.72 per share.	01 Feb 2022	333	35,888 (0%)	0%	3.7	1,239	Common Stock
Terry L. Murdock	Chief Operating Officer	Sale of securities on an exchange or to another person at price $ 10.61 per share.	03 Jan 2022	1,445	21,555 (0%)	0%	10.6	15,334	Common Stock
Terry L. Murdock	Chief Operating Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2022	12,000	23,000 (0%)	0%		0	Common Stock
Terry L. Murdock	Chief Operating Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2022	53,000	53,000	-		-	Stock Options (Right to buy)
Rajesh K. Malik	Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 10.61 per share.	03 Jan 2022	1,445	63,855 (0%)	0%	10.6	15,334	Common Stock
Rajesh K. Malik	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2022	53,000	53,000	-		-	Stock Options (Right to buy)
Rajesh K. Malik	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2022	12,000	65,300 (0%)	0%		0	Common Stock
Jennifer K. Moses	CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2022	12,000	37,000 (0%)	0%		0	Common Stock
Jennifer K. Moses	CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2022	53,000	53,000	-		-	Stock Options (Right to buy)
Jennifer K. Moses	CFO	Sale of securities on an exchange or to another person at price $ 10.61 per share.	03 Jan 2022	1,445	35,555 (0%)	0%	10.6	15,334	Common Stock
James S. Hanson	General Counsel	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2022	12,000	27,000 (0%)	0%		0	Common Stock
James S. Hanson	General Counsel	Sale of securities on an exchange or to another person at price $ 10.61 per share.	03 Jan 2022	1,445	25,555 (0%)	0%	10.6	15,334	Common Stock
James S. Hanson	General Counsel	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2022	53,000	53,000	-		-	Stock Options (Right to buy)
Mark Avagliano	Chief Business Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2022	53,000	53,000	-		-	Stock Options (Right to buy)
Mark Avagliano	Chief Business Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2022	12,000	23,000 (0%)	0%		0	Common Stock
Mark Avagliano	Chief Business Officer	Sale of securities on an exchange or to another person at price $ 10.61 per share.	03 Jan 2022	1,445	21,555 (0%)	0%	10.6	15,334	Common Stock
John E. Bailey	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2022	46,000	267,333 (0%)	0%		0	Common Stock
John E. Bailey	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2022	204,000	204,000	-		-	Stock Options (Right to buy)
John E. Bailey	Director, President and CEO	Sale of securities on an exchange or to another person at price $ 10.41 per share.	03 Jan 2022	34,125	233,208 (0%)	0%	10.4	355,262	Common Stock
Andrew Perry	Chief Commercial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2022	6,000	6,020 (0%)	0%		0	Common Stock
Andrew Perry	Chief Commercial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2022	26,500	26,500	-		-	Stock Options (Right to buy)
Mark A. Velleca	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.39 per share.	09 Nov 2021	40,000	101,000 (0%)	0%	0.4	15,600	Common Stock
Mark A. Velleca	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	09 Nov 2021	40,000	187,286	-		-	Stock Options (Right to Buy)
Andrew Perry	Chief Commercial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Aug 2021	300,000	300,000	-		-	Stock Options (Right to buy)
Mark A. Velleca	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	13 Jul 2021	10,000	237,286	-		-	Stock Options (Right to Buy)
Mark A. Velleca	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	13 Jul 2021	10,000	247,286	-		-	Stock Options (Right to Buy)
Mark A. Velleca	Director	Sale of securities on an exchange or to another person at price $ 18.49 per share.	13 Jul 2021	10,000	61,000 (0%)	0%	18.5	184,898	Common Stock
Mark A. Velleca	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.39 per share.	13 Jul 2021	10,000	71,000 (0%)	0%	0.4	3,900	Common Stock
Mark A. Velleca	Director	Sale of securities on an exchange or to another person at price $ 19.08 per share.	13 Jul 2021	10,000	61,000 (0%)	0%	19.1	190,824	Common Stock
Mark A. Velleca	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.39 per share.	13 Jul 2021	10,000	71,000 (0%)	0%	0.4	3,900	Common Stock
Mark A. Velleca	Director	Sale of securities on an exchange or to another person at price $ 19.45 per share.	13 Jul 2021	10,000	61,000 (0%)	0%	19.5	194,536	Common Stock
Mark A. Velleca	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.39 per share.	13 Jul 2021	10,000	71,000 (0%)	0%	0.4	3,900	Common Stock
Mark A. Velleca	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	13 Jul 2021	10,000	227,286	-		-	Stock Options (Right to Buy)
Seth Rudnick	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.30 per share.	29 Jun 2021	2,031	14,389 (0%)	0%	0.3	609	Common Stock
Seth Rudnick	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	29 Jun 2021	7,969	0	-		-	Stock Options (Right to Buy)
Seth Rudnick	Director	Sale of securities on an exchange or to another person at price $ 22.35 per share.	29 Jun 2021	10,000	4,389 (0%)	0%	22.3	223,477	Common Stock
Seth Rudnick	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.39 per share.	29 Jun 2021	7,969	12,358 (0%)	0%	0.4	3,108	Common Stock
Seth Rudnick	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	29 Jun 2021	2,031	11,859	-		-	Stock Option (Right to Buy)
Glenn P. Muir	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Jun 2021	4,389	175,358 (0%)	0%		0	Common Stock
Glenn P. Muir	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Jun 2021	19,620	19,620	-		-	Stock Options (Right to Buy)
Seth Rudnick	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Jun 2021	19,620	19,620	-		-	Stock Options (Right to Buy)
Seth Rudnick	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Jun 2021	4,389	4,389 (0%)	0%		0	Common Stock
Willie A. Deese	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Jun 2021	19,620	19,620	-		-	Stock Options (Right to Buy)
Willie A. Deese	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Jun 2021	4,389	4,389 (0%)	0%		0	Common Stock
Alicia Secor	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Jun 2021	52,320	52,320	-		-	Stock Options (Right to buy)
Garry A. Nicholson	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Jun 2021	19,620	19,620	-		-	Stock Options (Right to Buy)
Garry A. Nicholson	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Jun 2021	4,389	4,389 (0%)	0%		0	Common Stock
Cynthia L. Schwalm	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Jun 2021	19,620	19,620	-		-	Stock Options (Right to Buy)
Cynthia L. Schwalm	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Jun 2021	4,389	5,889 (0%)	0%		0	Common Stock
Mark A. Velleca	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.39 per share.	15 Jun 2021	10,000	71,000 (0%)	0%	0.4	3,900	Common Stock
Mark A. Velleca	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	15 Jun 2021	10,000	257,286	-		-	Stock Options (Right to Buy)
Mark A. Velleca	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	15 Jun 2021	10,000	267,286	-		-	Stock Options (Right to Buy)
Mark A. Velleca	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	15 Jun 2021	10,000	277,286	-		-	Stock Options (Right to Buy)
Mark A. Velleca	Director	Sale of securities on an exchange or to another person at price $ 21.77 per share.	15 Jun 2021	10,000	61,000 (0%)	0%	21.8	217,728	Common Stock
Mark A. Velleca	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.39 per share.	15 Jun 2021	10,000	71,000 (0%)	0%	0.4	3,900	Common Stock
Mark A. Velleca	Director	Sale of securities on an exchange or to another person at price $ 21.74 per share.	15 Jun 2021	10,000	61,000 (0%)	0%	21.7	217,384	Common Stock
Mark A. Velleca	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.39 per share.	15 Jun 2021	10,000	71,000 (0%)	0%	0.4	3,900	Common Stock
Mark A. Velleca	Director	Sale of securities on an exchange or to another person at price $ 22.39 per share.	15 Jun 2021	10,000	61,000 (0%)	0%	22.4	223,909	Common Stock
Mark A. Velleca	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	25 May 2021	20,000	287,286	-		-	Stock Options (Right to Buy)
Mark A. Velleca	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.39 per share.	25 May 2021	20,000	61,000 (0%)	0%	0.4	7,800	Common Stock
Mark A. Velleca	Director	Sale of securities on an exchange or to another person at price $ 19.10 per share.	11 May 2021	10,000	41,000 (0%)	0%	19.1	190,997	Common Stock
Mark A. Velleca	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	11 May 2021	10,000	307,286	-		-	Stock Options (Right to Buy)
Mark A. Velleca	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	11 May 2021	10,000	317,286	-		-	Stock Options (Right to Buy)
Mark A. Velleca	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	11 May 2021	10,000	327,286	-		-	Stock Options (Right to Buy)
Mark A. Velleca	Director	Sale of securities on an exchange or to another person at price $ 20.54 per share.	11 May 2021	10,000	41,000 (0%)	0%	20.5	205,413	Common Stock
Mark A. Velleca	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.39 per share.	11 May 2021	10,000	51,000 (0%)	0%	0.4	3,900	Common Stock
Mark A. Velleca	Director	Sale of securities on an exchange or to another person at price $ 20.07 per share.	11 May 2021	10,000	41,000 (0%)	0%	20.1	200,691	Common Stock
Mark A. Velleca	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.39 per share.	11 May 2021	10,000	51,000 (0%)	0%	0.4	3,900	Common Stock
Mark A. Velleca	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.39 per share.	11 May 2021	10,000	51,000 (0%)	0%	0.4	3,900	Common Stock
Rajesh K. Malik	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 May 2021	10,000	65,000	-		-	Stock Option (Right to Buy)
Rajesh K. Malik	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.30 per share.	10 May 2021	10,000	53,300 (0%)	0%	0.3	3,000	Common Stock
Rajesh K. Malik	Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 22.07 per share.	22 Apr 2021	15,000	43,300 (0%)	0%	22.1	331,100	Common Stock
Rajesh K. Malik	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.39 per share.	22 Apr 2021	15,000	58,300 (0%)	0%	0.4	5,850	Common Stock
Rajesh K. Malik	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	22 Apr 2021	15,000	39,439	-		-	Stock Options (Right to Buy)
Mark A. Velleca	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	13 Apr 2021	10,000	357,286	-		-	Stock Options (Right to Buy)
Mark A. Velleca	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.39 per share.	13 Apr 2021	10,000	51,000 (0%)	0%	0.4	3,900	Common Stock
Mark A. Velleca	Director	Sale of securities on an exchange or to another person at price $ 23.89 per share.	13 Apr 2021	10,000	41,000 (0%)	0%	23.9	238,865	Common Stock
Mark A. Velleca	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.39 per share.	13 Apr 2021	10,000	51,000 (0%)	0%	0.4	3,900	Common Stock
Mark A. Velleca	Director	Sale of securities on an exchange or to another person at price $ 24.53 per share.	13 Apr 2021	10,000	41,000 (0%)	0%	24.5	245,272	Common Stock
Mark A. Velleca	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.39 per share.	13 Apr 2021	10,000	51,000 (0%)	0%	0.4	3,900	Common Stock
Mark A. Velleca	Director	Sale of securities on an exchange or to another person at price $ 24.96 per share.	13 Apr 2021	10,000	41,000 (0%)	0%	25.0	249,631	Common Stock
Mark A. Velleca	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	13 Apr 2021	10,000	347,286	-		-	Stock Options (Right to Buy)
Mark A. Velleca	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	13 Apr 2021	10,000	337,286	-		-	Stock Options (Right to Buy)
Rajesh K. Malik	Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 21.94 per share.	23 Mar 2021	15,000	43,300 (0%)	0%	21.9	329,060	Common Stock
Rajesh K. Malik	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.39 per share.	23 Mar 2021	15,000	58,300 (0%)	0%	0.4	5,850	Common Stock
Rajesh K. Malik	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Mar 2021	15,000	54,439	-		-	Stock Options (Right to Buy)
Jennifer K. Moses	CFO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.72 per share.	03 Mar 2021	3,000	25,000 (0%)	0%	3.7	11,160	Common Stock
Jennifer K. Moses	CFO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	03 Mar 2021	3,000	333	-		-	Stock Options (Right to Buy)
Rajesh K. Malik	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.17 per share.	02 Mar 2021	4,595	58,300 (0%)	0%	4.2	19,161	Common Stock
Rajesh K. Malik	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	02 Mar 2021	4,595	36,924	-		-	Stock Option (Right to Buy)
Rajesh K. Malik	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	02 Mar 2021	10,405	69,439	-		-	Stock Options (Right to Buy)
Rajesh K. Malik	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.39 per share.	02 Mar 2021	10,405	53,705 (0%)	0%	0.4	4,058	Common Stock
Rajesh K. Malik	Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 22.95 per share.	02 Mar 2021	15,000	43,300 (0%)	0%	22.9	344,192	Common Stock
Mark A. Velleca	Director	Sale of securities on an exchange or to another person at price $ 36.22 per share.	16 Feb 2021	2,700	41,023 (0%)	0%	36.2	97,781	Common Stock
Mark A. Velleca	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.72 per share.	16 Feb 2021	11,040	52,040 (0%)	0%	3.7	41,069	Common Stock
Mark A. Velleca	Director	Sale of securities on an exchange or to another person at price $ 34.87 per share.	16 Feb 2021	8,317	43,723 (0%)	0%	34.9	290,021	Common Stock
Mark A. Velleca	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	16 Feb 2021	10,000	28,393	-		-	Stock Options (Right to Buy)
Mark A. Velleca	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	16 Feb 2021	10,000	38,393	-		-	Stock Options (Right to Buy)
Mark A. Velleca	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	16 Feb 2021	11,040	48,393	-		-	Stock Options (Right to Buy)
Mark A. Velleca	Director	Sale of securities on an exchange or to another person at price $ 26.02 per share.	16 Feb 2021	10,000	41,000 (0%)	0%	26.0	260,152	Common Stock
Mark A. Velleca	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.72 per share.	16 Feb 2021	10,000	51,000 (0%)	0%	3.7	37,200	Common Stock
Mark A. Velleca	Director	Sale of securities on an exchange or to another person at price $ 28.41 per share.	16 Feb 2021	600	41,000 (0%)	0%	28.4	17,046	Common Stock
Mark A. Velleca	Director	Sale of securities on an exchange or to another person at price $ 27.59 per share.	16 Feb 2021	9,400	41,600 (0%)	0%	27.6	259,387	Common Stock
Mark A. Velleca	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.72 per share.	16 Feb 2021	10,000	51,000 (0%)	0%	3.7	37,200	Common Stock
Mark A. Velleca	Director	Sale of securities on an exchange or to another person at price $ 37.00 per share.	16 Feb 2021	23	41,000 (0%)	0%	37	851	Common Stock
Rajesh K. Malik	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	27 Jan 2021	3,100	79,844	-		-	Stock Options (Right to Buy)
Rajesh K. Malik	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.39 per share.	27 Jan 2021	3,100	43,300 (0%)	0%	0.4	1,209	Common Stock
Rajesh K. Malik	Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 20.64 per share.	22 Jan 2021	15,000	40,200 (0%)	0%	20.6	309,591	Common Stock
Rajesh K. Malik	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	22 Jan 2021	15,000	41,519	-		-	Stock Option (Right to Buy)
Rajesh K. Malik	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.17 per share.	22 Jan 2021	15,000	55,200 (0%)	0%	4.2	62,550	Common Stock
Mark A. Velleca	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.72 per share.	19 Jan 2021	10,000	47,000 (0%)	0%	3.7	37,200	Common Stock
Mark A. Velleca	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	19 Jan 2021	10,000	59,433	-		-	Stock Options (Right to Buy)
Mark A. Velleca	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	19 Jan 2021	4,000	367,286	-		-	Stock Options (Right to Buy)
Mark A. Velleca	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	19 Jan 2021	10,000	69,433	-		-	Stock Options (Right to Buy)
Mark A. Velleca	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	19 Jan 2021	10,000	79,433	-		-	Stock Options (Right to Buy)
Mark A. Velleca	Director	Sale of securities on an exchange or to another person at price $ 20.64 per share.	19 Jan 2021	10,000	41,000 (0%)	0%	20.6	206,400	Common Stock
Mark A. Velleca	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.72 per share.	19 Jan 2021	10,000	51,000 (0%)	0%	3.7	37,200	Common Stock
Mark A. Velleca	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.39 per share.	19 Jan 2021	4,000	41,000 (0%)	0%	0.4	1,560	Common Stock
Mark A. Velleca	Director	Sale of securities on an exchange or to another person at price $ 21.51 per share.	19 Jan 2021	10,000	37,000 (0%)	0%	21.5	215,107	Common Stock
Mark A. Velleca	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.72 per share.	19 Jan 2021	10,000	47,000 (0%)	0%	3.7	37,200	Common Stock
Mark A. Velleca	Director	Sale of securities on an exchange or to another person at price $ 20.88 per share.	19 Jan 2021	10,000	37,000 (0%)	0%	20.9	208,781	Common Stock
Terry L. Murdock	Chief Operating Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	04 Jan 2021	58,000	58,000	-		-	Stock Options (Right to Buy)
Terry L. Murdock	Chief Operating Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	04 Jan 2021	11,000	11,000 (0%)	0%		0	Common Stock
Rajesh K. Malik	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	04 Jan 2021	58,000	58,000	-		-	Stock Options (Right to Buy)
Rajesh K. Malik	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	04 Jan 2021	11,000	40,200 (0%)	0%		0	Common Stock
Jennifer K. Moses	CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	04 Jan 2021	58,000	58,000	-		-	Stock Options (Right to Buy)
Jennifer K. Moses	CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	04 Jan 2021	11,000	22,000 (0%)	0%		0	Common Stock
James S. Hanson	General Counsel	Grant, award, or other acquisition of securities at price $ 0.00 per share.	04 Jan 2021	58,000	58,000	-		-	Stock Options (Right to Buy)
James S. Hanson	General Counsel	Grant, award, or other acquisition of securities at price $ 0.00 per share.	04 Jan 2021	11,000	15,000 (0%)	0%		0	Common Stock
Mark Avagliano	Chief Business Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	04 Jan 2021	58,000	58,000	-		-	Stock Options (Right to Buy)
Mark Avagliano	Chief Business Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	04 Jan 2021	11,000	11,000 (0%)	0%		0	Common Stock
Soma Gupta	Chief Commercial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	04 Jan 2021	58,000	58,000	-		-	Stock Options (Right to Buy)
Soma Gupta	Chief Commercial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	04 Jan 2021	11,000	11,000 (0%)	0%		0	Common Stock
John E. Bailey	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Jan 2021	213,333	221,333 (0%)	0%		0	Common Stock
John E. Bailey	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Jan 2021	320,000	320,000	-		-	Stock Options (Right to Buy)
Seth Rudnick	Director	Sale of securities on an exchange or to another person at price $ 20.10 per share.	24 Dec 2020	924	5,266 (0%)	0%	20.1	18,572	Common Stock
Seth Rudnick	Director	Sale of securities on an exchange or to another person at price $ 20.33 per share.	22 Dec 2020	18,974	19,308 (0%)	0%	20.3	385,702	Common Stock
Seth Rudnick	Director	Sale of securities on an exchange or to another person at price $ 20.18 per share.	22 Dec 2020	13,118	6,190 (0%)	0%	20.2	264,757	Common Stock
Mark A. Velleca	Director, President and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	15 Dec 2020	10,000	109,433	-		-	Stock Options (Right to Buy)
Mark A. Velleca	Director, President and CEO	Sale of securities on an exchange or to another person at price $ 19.97 per share.	15 Dec 2020	10,000	37,000 (0%)	0%	20.0	199,668	Common Stock
Mark A. Velleca	Director, President and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.72 per share.	15 Dec 2020	10,000	47,000 (0%)	0%	3.7	37,200	Common Stock
Mark A. Velleca	Director, President and CEO	Sale of securities on an exchange or to another person at price $ 19.20 per share.	15 Dec 2020	10,000	37,000 (0%)	0%	19.2	192,021	Common Stock
Mark A. Velleca	Director, President and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.72 per share.	15 Dec 2020	10,000	47,000 (0%)	0%	3.7	37,200	Common Stock
Mark A. Velleca	Director, President and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.72 per share.	15 Dec 2020	10,000	47,000 (0%)	0%	3.7	37,200	Common Stock
Mark A. Velleca	Director, President and CEO	Sale of securities on an exchange or to another person at price $ 19.43 per share.	15 Dec 2020	10,000	37,000 (0%)	0%	19.4	194,297	Common Stock
Mark A. Velleca	Director, President and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	15 Dec 2020	10,000	89,433	-		-	Stock Options (Right to Buy)
Mark A. Velleca	Director, President and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	15 Dec 2020	10,000	99,433	-		-	Stock Options (Right to Buy)
Rajesh K. Malik	Ch. Medical Officer & SVP R&D	Sale of securities on an exchange or to another person at price $ 20.06 per share.	10 Dec 2020	9,000	29,200 (0%)	0%	20.1	180,550	Common Stock
Rajesh K. Malik	Ch. Medical Officer & SVP R&D	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 Dec 2020	9,000	56,519	-		-	Stock Option (Right to Buy)
Rajesh K. Malik	Ch. Medical Officer & SVP R&D	Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.17 per share.	10 Dec 2020	9,000	38,200 (0%)	0%	4.2	37,530	Common Stock
Seth Rudnick	Director	Sale of securities on an exchange or to another person at price $ 20.32 per share.	08 Dec 2020	5,773	38,828 (0%)	0%	20.3	117,284	Common Stock
Seth Rudnick	Director	Sale of securities on an exchange or to another person at price $ 20.00 per share.	08 Dec 2020	546	38,282 (0%)	0%	20.0	10,921	Common Stock
Seth Rudnick	Director	Sale of securities on an exchange or to another person at price $ 20.19 per share.	08 Dec 2020	13,161	44,601 (0%)	0%	20.2	265,694	Common Stock
Seth Rudnick	Director	Sale of securities on an exchange or to another person at price $ 20.09 per share.	01 Dec 2020	520	57,762 (0%)	0%	20.1	10,449	Common Stock
Glenn P. Muir	Director	Purchase of securities on an exchange or from another person at price $ 13.50 per share.	18 Nov 2020	50,000	170,969 (0%)	0%	13.5	675,000	Common Stock
John E. Bailey	Director	Purchase of securities on an exchange or from another person at price $ 12.76 per share.	10 Nov 2020	4,000	4,000 (0%)	0%	12.8	51,055	Common Stock
John E. Bailey	Director	Purchase of securities on an exchange or from another person at price $ 12.83 per share.	10 Nov 2020	4,000	8,000 (0%)	0%	12.8	51,320	Common Stock
James S. Hanson	General Counsel	Purchase of securities on an exchange or from another person at price $ 14.95 per share.	04 Sep 2020	1,000	4,000 (0%)	0%	15.0	14,950	Common Stock
Fredric N. Eshelman	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 Jun 2020	20,000	20,000	-		-	Stock Option (right to buy)
Glenn P. Muir	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 Jun 2020	20,000	20,000	-		-	Stock Option (right to buy)
Seth Rudnick	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 Jun 2020	20,000	20,000	-		-	Stock Option (right to buy)
Willie A. Deese	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 Jun 2020	20,000	20,000	-		-	Stock Option (right to buy)
Garry A. Nicholson	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 Jun 2020	20,000	20,000	-		-	Stock Option (right to buy)
Cynthia L. Schwalm	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 Jun 2020	20,000	20,000	-		-	Stock Option (right to buy)
John E. Bailey	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 Jun 2020	20,000	20,000	-		-	Stock Option (right to buy)
Soma Gupta	Chief Commercial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2020	300,000	300,000	-		-	Stock Options (Right to Buy)
Rajesh K. Malik	Ch. Medical Officer & SVP R&D	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	13 Mar 2020	2,500	82,944	-		-	Stock Options (Right to Buy)
Rajesh K. Malik	Ch. Medical Officer & SVP R&D	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.39 per share.	13 Mar 2020	2,500	29,200 (0%)	0%	0.4	975	Common Stock
Mark A. Velleca	Director, President and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	13 Mar 2020	3,000	371,286	-		-	Stock Options (Right to Buy)
Mark A. Velleca	Director, President and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.39 per share.	13 Mar 2020	3,000	37,000 (0%)	0%	0.4	1,170	Common Stock
Jennifer K. Moses	CFO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.72 per share.	13 Mar 2020	2,000	11,000 (0%)	0%	3.7	7,440	Common Stock
Jennifer K. Moses	CFO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	13 Mar 2020	2,000	3,333	-		-	Stock Options (Right to Buy)
John E. Bailey	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Mar 2020	40,000	40,000	-		-	Stock Options (Right to Buy)
Terry L. Murdock	Chief Operating Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	06 Feb 2020	60,000	60,000	-		-	Stock Options (Right to Buy)
Rajesh K. Malik	Ch. Medical Officer & SVP R&D	Grant, award, or other acquisition of securities at price $ 0.00 per share.	06 Feb 2020	60,000	60,000	-		-	Stock Options (Right to Buy)
Mark A. Velleca	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	06 Feb 2020	220,000	220,000	-		-	Stock Options (Right to Buy)
Jennifer K. Moses	CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	06 Feb 2020	80,000	80,000	-		-	Stock Options (Right to Buy)
John Demaree	Chief Commercial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	06 Feb 2020	30,000	30,000	-		-	Stock Options (Right to Buy)
James S. Hanson	General Counsel	Grant, award, or other acquisition of securities at price $ 0.00 per share.	06 Feb 2020	60,000	60,000	-		-	Stock Options (Right to Buy)
Mark Avagliano	Chief Business Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	06 Feb 2020	60,000	60,000	-		-	Stock Options (Right to Buy)
Rajesh K. Malik	Ch. Medical Officer & SVP R&D	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jan 2020	5,000	85,444	-		-	Stock Options (Right to Buy)
Rajesh K. Malik	Ch. Medical Officer & SVP R&D	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.39 per share.	23 Jan 2020	5,000	26,700 (0%)	0%	0.4	1,950	Common Stock
Mark A. Velleca	Director, President and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.39 per share.	23 Jan 2020	6,000	34,000 (0%)	0%	0.4	2,340	Common Stock
Mark A. Velleca	Director, President and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jan 2020	6,000	374,286	-		-	Stock Options (Right to Buy)
Jennifer K. Moses	CFO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jan 2020	1,000	5,333	-		-	Stock Option (Right to Buy)
Jennifer K. Moses	CFO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.72 per share.	23 Jan 2020	1,000	9,000 (0%)	0%	3.7	3,720	Common Stock
Mark Avagliano	Chief Business Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jul 2019	300,000	300,000	-		-	Stock Option (Right to Buy)
Jennifer K. Moses	CFO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	18 Jul 2019	2,000	6,333	-		-	Stock Option (Right to Buy)
Jennifer K. Moses	CFO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.72 per share.	18 Jul 2019	2,000	8,000 (0%)	0%	3.7	7,440	Common Stock
Fredric N. Eshelman	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Jun 2019	20,000	20,000	-		-	Stock Option (right to buy)
Glenn P. Muir	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Jun 2019	20,000	20,000	-		-	Stock Option (right to buy)
Seth Rudnick	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Jun 2019	20,000	20,000	-		-	Stock Option (right to buy)
Willie A. Deese	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Jun 2019	20,000	20,000	-		-	Stock Option (right to buy)
Andrew P. Witty	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Jun 2019	20,000	20,000	-		-	Stock Option (right to buy)
Garry A. Nicholson	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Jun 2019	20,000	20,000	-		-	Stock Option (right to buy)
Garry A. Nicholson	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Jun 2019	100,000	100,000	-		-	Stock Option (right to buy)
Cynthia L. Schwalm	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Jun 2019	20,000	20,000	-		-	Stock Option (right to buy)
Jennifer K. Moses	CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 May 2019	50,000	50,000	-		-	Stock Options (Right to buy)
Rajesh K. Malik	Ch. Medical Officer & SVP R&D	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Jan 2019	7,000	90,444	-		-	Stock Options (Right to Buy)
Rajesh K. Malik	Ch. Medical Officer & SVP R&D	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.39 per share.	28 Jan 2019	7,000	21,700 (0%)	0%	0.4	2,730	Common Stock
Mark A. Velleca	Director, President and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Jan 2019	9,000	380,286	-		-	Stock Options (Right to Buy)
Mark A. Velleca	Director, President and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.39 per share.	17 Jan 2019	9,000	28,000 (0%)	0%	0.4	3,510	Common Stock
Jennifer K. Moses	VP of Finance	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Jan 2019	2,000	8,333	-		-	Stock Option (Right to Buy)
Jennifer K. Moses	VP of Finance	Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.72 per share.	17 Jan 2019	2,000	6,000 (0%)	0%	3.7	7,440	Common Stock
Barclay A. Phillips	SVP & Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2019	60,000	60,000	-		-	Stock Options (Right to Buy)
Terry L. Murdock	Chief Operating Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2019	60,000	60,000	-		-	Stock Options (Right to Buy)
Rajesh K. Malik	Ch. Medical Officer & SVP R&D	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2019	60,000	60,000	-		-	Stock Options (Right to Buy)
Mark A. Velleca	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2019	225,000	225,000	-		-	Stock Options (Right to Buy)
Jay Strum	Chief Scientific Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.39 per share.	02 Jan 2019	40,333	129,237 (0%)	0%	0.4	15,730	Common Stock
Jay Strum	Chief Scientific Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.30 per share.	02 Jan 2019	39,485	88,904 (0%)	0%	0.3	11,846	Common Stock
Jay Strum	Chief Scientific Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2019	15,000	15,000	-		-	Stock Option (Right to Buy)
Jay Strum	Chief Scientific Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	02 Jan 2019	13,333	0	-		-	Stock Option (Right to Buy)
Jay Strum	Chief Scientific Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	02 Jan 2019	10,336	0	-		-	Stock Option (Right to Buy)
Jay Strum	Chief Scientific Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	02 Jan 2019	15,816	0	-		-	Stock Option (Right to Buy)
Jay Strum	Chief Scientific Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	02 Jan 2019	27,000	0	-		-	Stock Option (Right to Buy)
Jay Strum	Chief Scientific Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	02 Jan 2019	13,333	0	-		-	Stock Option (Right to Buy)
Jennifer K. Moses	VP of Finance	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2019	20,000	20,000	-		-	Stock Options (Right to Buy)
John Demaree	Chief Commercial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2019	60,000	60,000	-		-	Stock Options (Right to Buy)
James S. Hanson	General Counsel	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2019	60,000	60,000	-		-	Stock Options (Right to Buy)
Cynthia L. Schwalm	None	Purchase of securities on an exchange or from another person at price $ 18.45 per share.	26 Dec 2018	1,420	1,500 (0%)	0%	18.4	26,196	Common Stock
James S. Hanson	General Counsel	Purchase of securities on an exchange or from another person at price $ 18.25 per share.	26 Dec 2018	1,000	3,000 (0%)	0%	18.3	18,250	Common Stock
Rajesh K. Malik	Ch. Medical Officer & SVP R&D	Sale of securities on an exchange or to another person at price $ 30.00 per share.	17 Dec 2018	3,776	14,700 (0%)	0%	30	113,280	Common Stock
Rajesh K. Malik	Ch. Medical Officer & SVP R&D	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Dec 2018	3,776	65,519	-		-	Stock Options (Right to Buy)
Rajesh K. Malik	Ch. Medical Officer & SVP R&D	Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.17 per share.	17 Dec 2018	3,776	18,476 (0%)	0%	4.2	15,746	Common Stock
John Demaree	Chief Commercial Officer	Purchase of securities on an exchange or from another person at price $ 33.15 per share.	10 Dec 2018	1,000	5,250 (0%)	0%	33.2	33,151	Common Stock
James S. Hanson	General Counsel	Purchase of securities on an exchange or from another person at price $ 32.51 per share.	10 Dec 2018	1,000	2,000 (0%)	0%	32.5	32,508	Common Stock
Jennifer K. Moses	VP of Finance & Admin	Sale of securities on an exchange or to another person at price $ 34.00 per share.	06 Dec 2018	750	2,000 (0%)	0%	34	25,500	Common Stock
Jennifer K. Moses	VP of Finance & Admin	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	06 Dec 2018	750	1,666	-		-	Stock Options (Right to Buy)
Jennifer K. Moses	VP of Finance & Admin	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	06 Dec 2018	2,000	10,333	-		-	Stock Option (Right to Buy)
Jennifer K. Moses	VP of Finance & Admin	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.39 per share.	06 Dec 2018	750	2,750 (0%)	0%	0.4	293	Common Stock
Jennifer K. Moses	VP of Finance & Admin	Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.72 per share.	06 Dec 2018	2,000	4,000 (0%)	0%	3.7	7,440	Common Stock
Seth Rudnick	None	Sale of securities on an exchange or to another person at price $ 39.31 per share.	04 Dec 2018	9,884	116 (0%)	0%	39.3	388,506	Common Stock
Seth Rudnick	None	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.39 per share.	04 Dec 2018	9,393	10,000 (0%)	0%	0.4	3,663	Common Stock
Seth Rudnick	None	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.39 per share.	04 Dec 2018	607	607 (0%)	0%	0.4	237	Common Stock
Seth Rudnick	None	Sale of securities on an exchange or to another person at price $ 40.00 per share.	04 Dec 2018	116	0 (0%)	0%	40	4,640	Common Stock
Seth Rudnick	None	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	04 Dec 2018	607	0	-		-	Stock Options (Right to Buy)
Seth Rudnick	None	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	04 Dec 2018	9,393	7,969	-		-	Stock Options (Right to Buy)
Terry L. Murdock	SVP of Development Operations	Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.51 per share.	03 Dec 2018	3,523	3,523 (0%)	0%	13.5	47,596	Common Stock
Terry L. Murdock	SVP of Development Operations	Sale of securities on an exchange or to another person at price $ 38.54 per share.	03 Dec 2018	3,523	0 (0%)	0%	38.5	135,779	Common Stock
Terry L. Murdock	SVP of Development Operations	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	03 Dec 2018	3,523	82,401	-		-	Stock Options (Right to Buy)
Barclay A. Phillips	SVP & Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	15 Nov 2018	5,000	95,000	-		-	Stock Options (Right to Buy)
Barclay A. Phillips	SVP & Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.46 per share.	15 Nov 2018	5,000	5,000 (0%)	0%	19.5	97,300	Common Stock
Barclay A. Phillips	SVP & Chief Financial Officer	Sale of securities on an exchange or to another person at price $ 39.92 per share.	15 Nov 2018	5,000	0 (0%)	0%	39.9	199,591	Common Stock
Rajesh K. Malik	Ch. Medical Officer & SVP R&D	Sale of securities on an exchange or to another person at price $ 40.32 per share.	15 Nov 2018	247	14,700 (0%)	0%	40.3	9,958	Common Stock
Rajesh K. Malik	Ch. Medical Officer & SVP R&D	Sale of securities on an exchange or to another person at price $ 39.71 per share.	15 Nov 2018	3,529	14,947 (0%)	0%	39.7	140,147	Common Stock
Rajesh K. Malik	Ch. Medical Officer & SVP R&D	Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.17 per share.	15 Nov 2018	3,776	18,476 (0%)	0%	4.2	15,746	Common Stock
Rajesh K. Malik	Ch. Medical Officer & SVP R&D	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	15 Nov 2018	3,776	69,295	-		-	Stock Options (Right to Buy)
Mark A. Velleca	Director, President and CEO	Sale of securities on an exchange or to another person at price $ 39.84 per share.	15 Nov 2018	4,985	19,015 (0%)	0%	39.8	198,602	Common Stock
Mark A. Velleca	Director, President and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.72 per share.	15 Nov 2018	5,000	24,000 (0%)	0%	3.7	18,600	Common Stock
Mark A. Velleca	Director, President and CEO	Sale of securities on an exchange or to another person at price $ 40.60 per share.	15 Nov 2018	15	19,000 (0%)	0%	40.6	609	Common Stock
Mark A. Velleca	Director, President and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	15 Nov 2018	5,000	119,433	-		-	Stock Options (Right to Buy)
Seth Rudnick	None	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	05 Nov 2018	10,000	607	-		-	Stock Options (Right to Buy)
Seth Rudnick	None	Sale of securities on an exchange or to another person at price $ 41.53 per share.	05 Nov 2018	10,000	0 (0%)	0%	41.5	415,347	Common Stock
Seth Rudnick	None	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.39 per share.	05 Nov 2018	10,000	10,000 (0%)	0%	0.4	3,900	Common Stock
Terry L. Murdock	SVP of Development Operations	Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.51 per share.	05 Nov 2018	3,519	3,519 (0%)	0%	13.5	47,542	Common Stock
Terry L. Murdock	SVP of Development Operations	Sale of securities on an exchange or to another person at price $ 41.53 per share.	05 Nov 2018	3,519	0 (0%)	0%	41.5	146,129	Common Stock
Terry L. Murdock	SVP of Development Operations	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	05 Nov 2018	3,519	85,924	-		-	Stock Options (Right to Buy)
Jennifer K. Moses	VP of Finance & Admin	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.39 per share.	05 Nov 2018	750	2,750 (0%)	0%	0.4	293	Common Stock
Jennifer K. Moses	VP of Finance & Admin	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	05 Nov 2018	750	2,416	-		-	Stock Options (Right to Buy)
Jennifer K. Moses	VP of Finance & Admin	Sale of securities on an exchange or to another person at price $ 41.38 per share.	05 Nov 2018	750	2,000 (0%)	0%	41.4	31,035	Common Stock
Rajesh K. Malik	Ch. Medical Officer & SVP R&D	Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.17 per share.	15 Oct 2018	3,776	12,176 (0%)	0%	4.2	15,746	Common Stock
Rajesh K. Malik	Ch. Medical Officer & SVP R&D	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.39 per share.	15 Oct 2018	6,300	14,700 (0%)	0%	0.4	2,457	Common Stock
Rajesh K. Malik	Ch. Medical Officer & SVP R&D	Sale of securities on an exchange or to another person at price $ 42.01 per share.	15 Oct 2018	2,833	8,400 (0%)	0%	42.0	119,019	Common Stock
Rajesh K. Malik	Ch. Medical Officer & SVP R&D	Sale of securities on an exchange or to another person at price $ 40.80 per share.	15 Oct 2018	943	11,233 (0%)	0%	40.8	38,478	Common Stock
Rajesh K. Malik	Ch. Medical Officer & SVP R&D	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	15 Oct 2018	3,776	73,071	-		-	Stock Options (Right to Buy)
Rajesh K. Malik	Ch. Medical Officer & SVP R&D	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	15 Oct 2018	6,300	97,444	-		-	Stock Option (Right to Buy)
Mark A. Velleca	Director, President and CEO	Sale of securities on an exchange or to another person at price $ 40.90 per share.	11 Oct 2018	2,163	21,837 (0%)	0%	40.9	88,469	Common Stock
Mark A. Velleca	Director, President and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	11 Oct 2018	10,000	389,286	-		-	Stock Options (Right to Buy)
Mark A. Velleca	Director, President and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	11 Oct 2018	5,000	124,433	-		-	Stock Options (Right to Buy)
Mark A. Velleca	Director, President and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.72 per share.	11 Oct 2018	5,000	24,000 (0%)	0%	3.7	18,600	Common Stock

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades disclosures

Insider Trading disclosures for G1 Therapeutics Inc

The latest disclosure was made by Glenn P. Muir in G1 Therapeutics Inc where a trade of 30,000 Stock Option (right to buy) done was reported to US exchanges on Sept. 18, 2024.

Screeners based on Insider Trading and SAST parameters